These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25409232)

  • 21. [Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy].
    Tang L; Lv F; Liu S; Zhang S
    Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3494-7. PubMed ID: 22368864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney targeting and modulating macrophage polarization through AMPK signaling: Therapeutic mechanism of berberine in uric acid nephropathy.
    Gong S; Chen J; Zheng X; Lu X; Chen M; Li J; Su Z; Liu Y; Chen J; Xie J; Xie Q; Li Y
    Int Immunopharmacol; 2024 Sep; 138():112632. PubMed ID: 38986300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway.
    Ren H; Shao Y; Wu C; Ma X; Lv C; Wang Q
    Mol Cell Endocrinol; 2020 Jan; 500():110628. PubMed ID: 31647955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation.
    Qiang G; Yang X; Shi L; Zhang H; Chen B; Zhao Y; Zu M; Zhou D; Guo J; Yang H; Zhang L; Du G
    Cell Physiol Biochem; 2015; 36(1):395-408. PubMed ID: 25967977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
    Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
    Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models.
    Huang K; Liu W; Lan T; Xie X; Peng J; Huang J; Wang S; Shen X; Liu P; Huang H
    PLoS One; 2012; 7(8):e43874. PubMed ID: 22937115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase.
    Liu WH; Hei ZQ; Nie H; Tang FT; Huang HQ; Li XJ; Deng YH; Chen SR; Guo FF; Huang WG; Chen FY; Liu PQ
    Chin Med J (Engl); 2008 Apr; 121(8):706-12. PubMed ID: 18701023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes.
    Jang J; Jung Y; Seo SJ; Kim SM; Shim YJ; Cho SH; Chung SI; Yoon Y
    Mol Med Rep; 2017 Jun; 15(6):4139-4147. PubMed ID: 28487951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice.
    Han YC; Tang SQ; Liu YT; Li AM; Zhan M; Yang M; Song N; Zhang W; Wu XQ; Peng CH; Zhang H; Yang S
    Cell Death Dis; 2021 Oct; 12(10):925. PubMed ID: 34628484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine attenuates apoptosis in rat retinal Müller cells stimulated with high glucose via enhancing autophagy and the AMPK/mTOR signaling.
    Chen H; Ji Y; Yan X; Su G; Chen L; Xiao J
    Biomed Pharmacother; 2018 Dec; 108():1201-1207. PubMed ID: 30372821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine suppresses proinflammatory responses through AMPK activation in macrophages.
    Jeong HW; Hsu KC; Lee JW; Ham M; Huh JY; Shin HJ; Kim WS; Kim JB
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E955-64. PubMed ID: 19208854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin.
    Wu D; Wen W; Qi CL; Zhao RX; Lü JH; Zhong CY; Chen YY
    Phytomedicine; 2012 Jun; 19(8-9):712-8. PubMed ID: 22483555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms.
    Ni WJ; Ding HH; Tang LQ
    Eur J Pharmacol; 2015 Aug; 760():103-12. PubMed ID: 25912800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice.
    Cai ZY; Wang CL; Lu TT; Yang WM
    Curr Mol Med; 2019; 19(5):342-348. PubMed ID: 30873920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.
    Yang Z; Li J; Xiong F; Huang J; Chen C; Liu P; Huang H
    Exp Cell Res; 2016 Aug; 346(2):241-7. PubMed ID: 27292312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective Activation of AMPK
    Salatto CT; Miller RA; Cameron KO; Cokorinos E; Reyes A; Ward J; Calabrese MF; Kurumbail RG; Rajamohan F; Kalgutkar AS; Tess DA; Shavnya A; Genung NE; Edmonds DJ; Jatkar A; Maciejewski BS; Amaro M; Gandhok H; Monetti M; Cialdea K; Bollinger E; Kreeger JM; Coskran TM; Opsahl AC; Boucher GG; Birnbaum MJ; DaSilva-Jardine P; Rolph T
    J Pharmacol Exp Ther; 2017 May; 361(2):303-311. PubMed ID: 28289077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
    Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
    Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
    J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-nephritic activity of a polysaccharide from okra (Abelmoschus esculentus (L.) Moench) via modulation of AMPK-Sirt1-PGC-1α signaling axis mediated anti-oxidative in type 2 diabetes model mice.
    Liao Z; Zhang J; Wang J; Yan T; Xu F; Wu B; Xiao F; Bi K; Niu J; Jia Y
    Int J Biol Macromol; 2019 Nov; 140():568-576. PubMed ID: 31442509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.